Search

Your search keyword '"Peter Eichhorn"' showing total 214 results

Search Constraints

Start Over You searched for: Author "Peter Eichhorn" Remove constraint Author: "Peter Eichhorn"
214 results on '"Peter Eichhorn"'

Search Results

51. Mauern : Sicherheit contra Freiheit

52. Unser täglich Bier gib uns heute : Das Bierwort für den Tag

53. Provinz hat Potential

54. Ohnmacht der Städte : Neue Aufgaben für Bürgermeister und Stadträte

57. 4-Amino-7,8-dihydro-1,6-naphthyridin-5(6 H)-ones as Inhaled Phosphodiesterase Type 4 (PDE4) Inhibitors: Structural Biology and Structure-Activity Relationships

58. Individuals and Institutions in the Economy

59. Calculating Economic Efficiency

60. Goals, Production Factors and Results

61. Economic Efficiency in Practice

63. A Principle for Action

64. Economies and Needs

65. Understanding Economic Activity

66. F107. CSF abnormalities in schizophrenia and depression: preliminary results from a large scale cohort

67. The Conceptual Basis

68. Principles of Management : Efficiency and Effectiveness in the Private and Public Sector

69. A novel inhaled Syk inhibitor blocks mast cell degranulation and early asthmatic response

70. Structure elucidation of phototransformation products of unapproved analogs of the erectile dysfunction drug sildenafil in artificial freshwater with UPLC-Q Exactive-MS

72. No need for NMDA receptor antibody screening in neurologically asymptomatic patients with ovarian teratomas

73. Using MALDI-TOF MS imaging and LC-HRMS for the investigation of the degradation of polycaprolactone diol exposed to different wastewater treatments

74. Metabolite profiling of carbamazepine and ibuprofen in Solea senegalensis bile using high-resolution mass spectrometry

75. Identification of the flotillin-1/2 heterocomplex as a target of autoantibodies in bona fide multiple sclerosis

76. Characterization of the chloroquine-induced mouse model of pruritus using an automated behavioural system

78. Structure–activity relationships (SAR) and structure–kinetic relationships (SKR) of bicyclic heteroaromatic acetic acids as potent CRTh2 antagonists II: Lead optimization

79. Structure–activity relationships (SAR) and structure–kinetic relationships (SKR) of pyrrolopiperidinone acetic acids as CRTh2 antagonists

81. 2-(1H-Pyrazol-1-yl)acetic acids as chemoattractant receptor-homologous molecule expressed on Th2 lymphocytes (CRTh2) antagonists

82. Biphenyl Pyridazinone Derivatives as Inhaled PDE4 Inhibitors: Structural Biology and Structure-Activity Relationships

83. Applications of Time-of-Flight and Orbitrap Mass Spectrometry in Environmental, Food, Doping, and Forensic Analysis

84. Federal States instead of National States

85. Polyspecific, antiviral immune response distinguishes multiple sclerosis and neuromyelitis optica

86. Pharmacological characterization of CRTh2 antagonist LAS191859: Long receptor residence time translates into long-lasting in vivo efficacy

87. Conclusions and Future Directions

90. Preface

92. Ziele, Faktoren und Wirkungsanalyse

93. Wirtschaft als Untersuchungsgegenstand

94. Wirtschaftende Personen und Institutionen

95. Anwendungsfelder der Wirtschaftlichkeit

96. Wirtschaftlichkeit als Handlungsprinzip

97. Identification of phototransformation products of sildenafil (Viagra) and its N-demethylated human metabolite under simulated sunlight

98. Immune-mediated liver diseases: programmed cell death ligands and circulating apoptotic markers

100. Pharmacological profile of a novel, potent and oral TRPA1 antagonist. Characterization in a preclinical model of induced cough

Catalog

Books, media, physical & digital resources